Global PDX Models Market is Expected to Reach USD 290.14 Million by 2025 : Fior Markets

NEXT STORY
Orchard Therapeutics Appoints Industry Veteran Steven Altschuler, M.D. to its Board of Directors
PREV STORY
Galecto Appoints Industry Leader Bertil Lindmark, MD, PhD, as Chief Medical Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

Enrollment on Track for Phase 1 Trial of XMT-1522 Patients with Advanced Tumors Expressing ...

author_avatar
NASDAQ Market News

ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.

author_avatar
NASDAQ Market News

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

author_avatar
NASDAQ Market News